Balanced news tone
News Sentiment
SANN sentiment intelligence
Santhera Pharmaceuticals Holding AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+2.8% over one week, -2.4% over four weeks, trend active, and materially above fair value.
Santhera Pharmaceuticals Holding AG (SANN.SW) Stock Price, Chart, News & Analysis
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Santhera Pharmaceuticals Holding AG (SANN.SW) Stock Price, Chart, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 01:25
- Source
- Securities.io
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jul 2026 05:00
- Source
- marketscreener.com
Little Excitement Around Santhera Pharmaceuticals Holding AG's (VTX:SANN) Revenues
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jan 2026 08:00
- Source
- simplywall.st
SANTHERA PHARMACEUTICALS HOLDING AG
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2023 04:13
- Source
- marketscreener.com